Director Global Oncology Marketing sac-TMT jobs in United States
cer-icon
Apply on Employer Site
company-logo

Merck · 20 hours ago

Director Global Oncology Marketing sac-TMT

Merck is dedicated to delivering breakthrough innovations that extend and improve the lives of cancer patients worldwide. They are seeking a Global Marketing Director to lead the commercial strategy and execution for sac-TMT, a TROP2 antibody drug conjugate, focusing on early launches and collaboration with cross-functional teams.

BiotechnologyHealth CareMedicalPharmaceutical
check
Comp. & Benefits
badNo H1Bnote

Responsibilities

Leading the commercial strategy development for specific indications for sac-TMT (TBD), including driving the development of indication-level L3 and other marketing strategy-related asset deliverables, scientific narrative and any relevant unbranded strategy work, in close collaboration with relevant disease teams, ensuring consistency and cohesion with the overarching sac-TMT asset strategy and relevant disease portfolio strategies
Includes responsibilities for market research, SL insights and other related insight-gathering needs for relevant indications
Includes coordination with precision medicine team on biomarker strategies related to relevant indications
Leading commercial planning and execution for relevant indications for sac-TMT, including:
Development of promotional strategies, messaging and any necessary global content deliverables, in collaboration with relevant disease teams, and ensuring consistency and cohesion with the overarching sac-TMT asset strategy and relevant disease portfolio strategies
AOR oversight and management
Management of the launch planning process for sac-TMT for relevant indication-level work, ensuring close cross-functional and cross-geographic coordination
SL engagement/congress strategy for relevant launch indications, in coordination with relevant disease teams and broader sac-TMT asset planning workstreams
Data analytics, performance metrics tracking for relevant indications, in close coordination with relevant disease teams and sac-TMT analytics team
Coordination with precision medicine team on commercialization of TROP2 CDx for relevant indications
Preparation for launch readiness and other governance discussions related to the relevant indications of sac-TMT
Coaching, guiding and development of direct reports, gig assignments, etc

Qualification

Oncology MarketingCommercial StrategiesStrategy DevelopmentProduct StrategiesMarket AssessmentsLaunch ReadinessBiopharmaceutical IndustryArtificial Intelligence StrategyExecutive PresenceMarketing StrategiesStrategic Communication ManagementStrategic Thinking

Required

Bachelor's Degree
Minimum 8+ years Pharmaceutical Business experience - marketing, sales, market access & pricing, marketing support or related experiences in pharmaceutical or biotechnology industries
Understanding of healthcare trends and reimbursement and policy issues and their potential impact upon our Company's business opportunities
Experience leading strategy development and implementation
Strong business acumen and ability to drive forward key initiatives
Strong collaboration skills, both within commercial teams and cross divisional teams
Strong leadership, problem solving, teamwork, analytical, written/verbal communication, and presentation skills
Ability to clearly articulate messages/information across the enterprise and to leadership
Ability to work within complex organizations and markets and leading sub-teams and influencing without authority

Preferred

Advanced Degree (i.e. MBA)
Global Marketing experience
Regional/Local Marketing experience
Launch experience
Oncology experience
Pipeline/early development experience
People management experience

Benefits

Medical
Dental
Vision healthcare
Other insurance benefits (for employee and family)
Retirement benefits, including 401(k)
Paid holidays
Vacation
Compassionate and sick days

Company

Merck is a biopharmaceutical company that offers medicines and vaccines for various diseases.

Funding

Current Stage
Public Company
Total Funding
$5.59M
Key Investors
Private Capital AdvisorsGavi, the Vaccine Alliance
2018-11-25Post Ipo Equity· $0.59M
2016-01-21Series Unknown· $5M
1980-12-19IPO

Leadership Team

leader-logo
Betty Larson
Executive Vice President and Chief Human Resources Officer
linkedin
leader-logo
Dean Li
Executive Vice President and President, Merck Research Laboratories
linkedin
Company data provided by crunchbase